Impact of BK polyomavirus viremia on the outcomes of allogeneic hematopoietic stem cell transplantation.
Allogeneic hematopoietic stem cell transplantation
BK Polyomavirus
Hemorrhagic cystitis
Renal function
Viremia
Journal
Annals of hematology
ISSN: 1432-0584
Titre abrégé: Ann Hematol
Pays: Germany
ID NLM: 9107334
Informations de publication
Date de publication:
21 Mar 2024
21 Mar 2024
Historique:
received:
04
01
2024
accepted:
11
03
2024
medline:
21
3
2024
pubmed:
21
3
2024
entrez:
21
3
2024
Statut:
aheadofprint
Résumé
Although it is known that BK polyomavirus (BKPyV) causes hemorrhagic cystitis (HC) after allogeneic hematopoietic stem cell transplantation (HSCT), the clinical significance of BKPyV viremia has not been fully evaluated. We retrospectively analyzed the results of quantitative polymerase chain reaction (PCR) evaluations for detecting BKPyV in the whole blood samples of patients undergoing allogeneic HSCT during the period from January 2010 to June 2020 at a single institute, Tokyo Medical and Dental University. BKPyV was detected in the blood of 28 of the 107 evaluated patients, and the cumulative incidence of was 27.9% (95%CI: 20.2-37.9%). HC due to BKPyV developed in four of the 28 patients with BKPyV viremia (14.3%) and in two of the 79 patients without it (2.5%; P < 0.05). BKPyV viremia itself did not affect the patients' post-transplant estimated glomerular filtration rate (eGFR), but BKPyV viremia with a high viral load was significantly associated with decreased eGFR values (P < 0.05). BKPyV viremia was also associated with significantly lower progression-free survival at 3 years (35.1% [95%CI: 17.8-53.1%] vs. 60.4% [95%CI: 48.4-70.5], P < 0.05). Our findings demonstrated that BKPyV viremia was associated with onset of HC, an early decline of renal function, and poorer survival after allogeneic HSCT. Further studies are needed to test these results and elucidate the mechanisms of renal dysfunction associated with BKPyV viremia.
Identifiants
pubmed: 38509389
doi: 10.1007/s00277-024-05707-x
pii: 10.1007/s00277-024-05707-x
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Saade A, Styczynski J, Cesaro S (2020) BK virus infection in allogeneic hematopoietic cell transplantation: an update on pathogenesis, immune responses, diagnosis and treatments: BK Polyoma virus infection. J Infect 81:372–382
doi: 10.1016/j.jinf.2020.06.009
pubmed: 32526327
Reploeg MD, Storch GA, Clifford DB (2001) BK virus: a clinical review. Clin Infect Dis 33:191–202
doi: 10.1086/321813
pubmed: 11418879
Fishman JA (2002) BK virus nephropathy – polyomavirus adding insult to injury. N Engl J Med 347:527–530
doi: 10.1056/NEJMe020076
pubmed: 12181409
Leung AYH, Suen CKM, Lie AKW, Liang RHS, Yuen KY, Kwong YL (2001) Quantification of polyoma BK Viruria in hemorrhagic cystitis complicating bone marrow transplantation. Blood 98:1971–1978
doi: 10.1182/blood.V98.6.1971
pubmed: 11535537
Wong ASY, Chan KH, Cheng VCC, Yuen KY, Kwong YL, Leung AYH (2007) Relationship of pretransplantation polyoma BK virus serologic findings and BK viral reactivation after hematopoietic stem cell transplantation. Clin Infect Dis 44:830–837
doi: 10.1086/511863
pubmed: 17304456
Ghosh A, Tan TT, Linn YC et al (2016) What we learned from plasma BK-virus monitoring in allogeneic hematopoietic transplant recipients. Transplantation 100:e17–e18
doi: 10.1097/TP.0000000000001103
pubmed: 26998851
Cesaro S, Dalianis T, Rinaldo CH et al (2018) ECIL guidelines for the prevention, diagnosis and treatment of BK Polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients. J Antimicrob Chemother 73:12–21
pubmed: 29190347
Armand P, Kim HT, Logan BR et al (2014) Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation. Blood 123:3664–3671
doi: 10.1182/blood-2014-01-552984
pubmed: 24744269
pmcid: 4047501
Yonese I, Sakashita C, Imadome KI et al (2020) Nationwide survey of systemic chronic active EBV infection in Japan in accordance with the new WHO classification. Blood Adv 4:2918–2926
doi: 10.1182/bloodadvances.2020001451
pubmed: 32598475
pmcid: 7362364
Nagasawa M, Mitsuiki N, Endo A et al (2016) Sequential virus monitoring of pediatric patients with hematopoietic stem cell transplantation by multiplex PCR method. Trends Transpl 9:1–8
doi: 10.15761/TiT.1000208
Herman J, Van Ranst M, Snoeck R, Beuselinck K, Lerut E, Van Damme-Lombaerts R (2004) Polyomavirus infection in pediatric renal transplant recipients: evaluation using a quantitative real-time PCR technique. Pediatr Transpl 8:485–492
doi: 10.1111/j.1399-3046.2004.00211.x
Kawamura K, Hayakawa J, Akahoshi Y et al (2015) Low-dose acyclovir prophylaxis for the prevention of herpes simplex virus and varicella zoster virus diseases after autologous hematopoietic stem cell transplantation. Int J Hematol 102:230–237
doi: 10.1007/s12185-015-1810-4
pubmed: 25990803
Kanda Y (2013) Investigation of the freely available easy-to-use software EZR for medical statistics. Bone Marrow Transpl 48:452–458
doi: 10.1038/bmt.2012.244
O’Donnell PH, Swanson K, Josephson MA et al (2009) BK virus infection is associated with hematuria and renal impairment in recipients of allogeneic hematopoetic stem cell transplants. Biol Blood Marrow Transpl 15:1038–1048e1
doi: 10.1016/j.bbmt.2009.04.016
Erard V, Storer B, Corey L et al (2004) BK virus infection in hematopoietic stem cell transplant recipients: frequency, risk factors, and association with postengraftment hemorrhagic cystitis. Clin Infect Dis 39:1861–1865
doi: 10.1086/426140
pubmed: 15578413
Gilis L, Morisset S, Billaud G et al (2014) High burden of BK virus-associated hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantation. Bone Marrow Transpl 649:664–670
doi: 10.1038/bmt.2013.235
Rorije NMG, Shea MM, Satyanarayana G et al (2014) BK virus disease after allogeneic stem cell transplantation: a cohort analysis. Biol Blood Marrow Transpl 20:564–570
doi: 10.1016/j.bbmt.2014.01.014
Abudayyeh A, Hamdi A, Lin H et al (2016) Symptomatic BK Virus infection is associated with kidney function decline and poor overall survival in allogeneic hematopoietic stem cell recipients. Am J Transpl 16:1492–1502
doi: 10.1111/ajt.13635
Ginevri F, Azzi A, Hirsch HH et al (2007) Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients. Am J Transpl 7:2727–2735
doi: 10.1111/j.1600-6143.2007.01984.x
Hirsch HH, Knowles W, Dickenmann M et al (2002) Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 347:488–496
doi: 10.1056/NEJMoa020439
pubmed: 12181403
Hirsch HH, Randhawa P (2013) BK Polyomavirus in solid organ transplantation. Am J Transpl 13:179–188
doi: 10.1111/ajt.12110
KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients (2009) Kidney disease: improving global outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Special Issue: Am J Transpl 9(Suppl 3):S1–S157
Kemmner S, Verbeek M, Heemann U (2017) Renal dysfunction following bone marrow transplantation. J Nephrol 30:201–209
doi: 10.1007/s40620-016-0345-y
pubmed: 27589851
Parikh CR, McSweeney P, Schrier RW (2005) Acute renal failure independently predicts mortality after myeloablative allogeneic hematopoietic cell transplant. Kidney Int 67:1999–2005
doi: 10.1111/j.1523-1755.2005.00301.x
pubmed: 15840050